
Should we shift away from unselective screening panels and test only whenresults directly alter clinical management?
This episode of Hemostasis Pulse highlights high-yieldclinical indications—such as atypical site thrombosis and targeted familyscreening—while emphasizing the critical timing of evaluation.
For laboratory specialists, we break down DOAC analytical interferencesand practical neutralization strategies to ensure diagnostic accuracy.
Master the diagnostic workflow for Antiphospholipid Syndrome (APS)using the sequential screening–mixing–confirmation protocol (dRVVT, APTT-LA)aligned with ISTH guidelines.
Avoid diagnostic pitfalls by clearly differentiating transient acquireddrops from true inherited deficiencies (Antithrombin, Protein C, and ProteinS).
Tunein to this 40-minute expert discussion
Fler avsnitt från "Hemostasis Pulse"



Missa inte ett avsnitt av “Hemostasis Pulse” och prenumerera på det i GetPodcast-appen.





